| Dr Naomi S Bardach, MD | |
|
1001 Potrero Ave, Mail Stop 6e, San Francisco, CA 94110-3518 | |
| (415) 206-8361 | |
| (415) 206-3686 |
| Full Name | Dr Naomi S Bardach |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 1001 Potrero Ave, San Francisco, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023049111 | NPI | - | NPPES |
| 00A918910 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | A91891 (California) | Primary |
| Entity Name | City & County Of San Francisco |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982737524 PECOS PAC ID: 1658280748 Enrollment ID: O20050309000770 |
News Archive
Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that the US Food and Drug Administration (FDA) has approved its New Drug Application for Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% as a treatment for acute herpetic keratitis (dendritic ulcers). The FDA granted orphan drug designation to Zirgan for this indication in April 2007.
For the first time, scientists have discovered how C-reactive protein, or CRP, is able to access endothelial cells. The UC Davis researchers' findings will be published in the July issue of Arteriosclerosis, Thrombosis, and Vascular Biology, one of the American Heart Association's leading journals.
The field is abuzz with the word "prevention," but how to pull off this vaunted goal? It's been held back by a strange Catch-22 of cost, time, and biomarker validation. That might change with a bold initiative led by Eric Reiman, Pierre Tariot, and others at the Banner Alzheimer's Institute. For the past two years, they have been laying the groundwork for what they hope will be an era of collaborative prevention research of shared risks and shared rewards.
KineMed, Inc. a translational and personalized medicine development company, today announced a broadening of its collaboration with Bristol-Myers Squibb Company (NYSE: BMY) in the area of Alzheimer's disease and other neurodegenerative conditions.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Naomi S Bardach, MD 1001 Potrero Ave, Mail Stop 6e, San Francisco, CA 94110-3518 Ph: (415) 206-8361 | Dr Naomi S Bardach, MD 1001 Potrero Ave, Mail Stop 6e, San Francisco, CA 94110-3518 Ph: (415) 206-8361 |
News Archive
Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that the US Food and Drug Administration (FDA) has approved its New Drug Application for Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% as a treatment for acute herpetic keratitis (dendritic ulcers). The FDA granted orphan drug designation to Zirgan for this indication in April 2007.
For the first time, scientists have discovered how C-reactive protein, or CRP, is able to access endothelial cells. The UC Davis researchers' findings will be published in the July issue of Arteriosclerosis, Thrombosis, and Vascular Biology, one of the American Heart Association's leading journals.
The field is abuzz with the word "prevention," but how to pull off this vaunted goal? It's been held back by a strange Catch-22 of cost, time, and biomarker validation. That might change with a bold initiative led by Eric Reiman, Pierre Tariot, and others at the Banner Alzheimer's Institute. For the past two years, they have been laying the groundwork for what they hope will be an era of collaborative prevention research of shared risks and shared rewards.
KineMed, Inc. a translational and personalized medicine development company, today announced a broadening of its collaboration with Bristol-Myers Squibb Company (NYSE: BMY) in the area of Alzheimer's disease and other neurodegenerative conditions.
› Verified 2 days ago
Dr. Kathryn Rachel Davis, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 505 Parnassus Ave # 0110, University Of California San Francisco, M691, San Francisco, CA 94143 Phone: 415-476-6245 | |
Dr. David Michael Gordon, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 505 Parnassus Ave # M696, Box 0110, San Francisco, CA 94143 Phone: 415-353-1000 | |
Jayme Congdon, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1500 Owens St, San Francisco, CA 94158 Phone: 415-476-1000 | |
Laurie Song, Pediatrics Medicare: Medicare Enrolled Practice Location: 550 16th St, San Francisco, CA 94158 Phone: 415-514-4079 Fax: 415-476-5354 | |
Ms. Tatiana Goldstein, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 525 Spruce Street, Suite 3, San Francisco, CA 94118 Phone: 415-668-8900 Fax: 415-668-1695 | |
John T Tsukahara, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2340 Clay St, 3rd Floor, San Francisco, CA 94115 Phone: 415-600-1111 | |
William Bernard Solomon, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 45 Castro Street, Suite 232, San Francisco, CA 94114 Phone: 415-565-6810 Fax: 415-565-6844 |